Scholarlink

<p>The efficacy and safety of transdermal dissolvable microneedle array patch (MNAP) in enhancing topical anesthesia delivery was studied in transfusion-dependent thalassemia children who had intravenous cannulation (IVC) for blood transfusion. We also compared the use of skin conductance algesimeter index (SCAI) as a pain assessment tool against the visual analog score (VAS) in these children with ages between 6 and 17 years, who had the topical anesthetic cream (EMLA) applied on the hand dorsum before IVC. This was a double-blind, randomized crossover trial involving 19 children with each child randomized to four intervention arms sequentially: MNAP and 1 finger-tip-unit (FTU) EMLA applied for 30&#xa0;min (A), MNAP and 0.5 FTU EMLA for 30&#xa0;min (B); MNAP and 1 FTU EMLA for 15&#xa0;min (C); and no MNAP (sham) patch and 1FTU EMLA for 30&#xa0;min (D), before IVC. The primary and secondary endpoints were, respectively, VAS and SCAI scores measured immediately after IVC. The MNAP with 1 FTU EMLA for 30&#xa0;min resulted in significantly lower VAS scores than sham patch [Mean<sub>MNAP</sub> (SE),1.839 (0.560) vs. [Mean<sub>sham</sub> (SE): 3.063 (0.534); <i>p</i> = 0.048], but not SCAI [Mean<sub>MNAP</sub> (SE): 0.200 (0.024) versus Mean<sub>sham</sub> (SE): 0.203 (0.026); <i>p</i> = 0.926]. The SCAI was not significantly correlated with VAS for all groups (<i>r</i> = -0.040 to 0.378; p (all) &gt; 0.05). Only 1 participant reported pruritus as a mild adverse event. The MNAP is a safe adjunct method to enhance effectiveness of pain relief from EMLA skin anesthetic before IVC.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Randomized double-blind crossover trial of a transdermal maltose dissolvable microneedle patch for topical anesthesia before intravenous cannulation for thalassemia children

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月29日

查看全文
  • Muhammad Irfan Abdul Jalal,
  • Kai Shen Ooi,
  • Kai Cheong Foo,
  • Azrul Azlan Hamzah,
  • Chang Fu Dee,
  • Poh Choon Ooi,
  • Muhammad Ramdzan Buyong,
  • Arifah Syahirah Abdul Rahman,
  • Teck Yew Low,
  • Xin Yun Chua,
  • Doris Sie Chong Lau,
  • Fook Choe Cheah

摘要

The efficacy and safety of transdermal dissolvable microneedle array patch (MNAP) in enhancing topical anesthesia delivery was studied in transfusion-dependent thalassemia children who had intravenous cannulation (IVC) for blood transfusion. We also compared the use of skin conductance algesimeter index (SCAI) as a pain assessment tool against the visual analog score (VAS) in these children with ages between 6 and 17 years, who had the topical anesthetic cream (EMLA) applied on the hand dorsum before IVC. This was a double-blind, randomized crossover trial involving 19 children with each child randomized to four intervention arms sequentially: MNAP and 1 finger-tip-unit (FTU) EMLA applied for 30 min (A), MNAP and 0.5 FTU EMLA for 30 min (B); MNAP and 1 FTU EMLA for 15 min (C); and no MNAP (sham) patch and 1FTU EMLA for 30 min (D), before IVC. The primary and secondary endpoints were, respectively, VAS and SCAI scores measured immediately after IVC. The MNAP with 1 FTU EMLA for 30 min resulted in significantly lower VAS scores than sham patch [MeanMNAP (SE),1.839 (0.560) vs. [Meansham (SE): 3.063 (0.534); p = 0.048], but not SCAI [MeanMNAP (SE): 0.200 (0.024) versus Meansham (SE): 0.203 (0.026); p = 0.926]. The SCAI was not significantly correlated with VAS for all groups (r = -0.040 to 0.378; p (all) > 0.05). Only 1 participant reported pruritus as a mild adverse event. The MNAP is a safe adjunct method to enhance effectiveness of pain relief from EMLA skin anesthetic before IVC.